Senior Director, Business Development, Biologics
Our mission is to make biology easier to engineer. Ginkgo is constructing, editing, and redesigning the living world in order to answer the globe’s growing challenges in health, energy, food, materials, and more. Our bioengineers make use of an in-house automated foundry for designing and building new organisms.
Senior Director, Business Development, Datapoints Biologics
About Ginkgo Datapoints: Ginkgo Datapoints, a newly established business unit within Ginkgo Bioworks, is poised to usher in the coming era of AI-backed biotechnology breakthroughs. By leveraging Ginkgo's state-of-the-art automation and digital infrastructure, Datapoints aims to address the growing demand for high-quality, large-scale biological datasets essential for training AI models in drug discovery and development. Unlock AI to unlock biology.
Job Description
In this role, you will spearhead the business development and sales strategy for Ginkgo Datapoints' Biologics products. This includes optimizing go-to-market strategies, representing the company at conferences and meetings, identifying and building relationships with customers, scoping and quoting work, and driving sales to achieve revenue targets. You will collaborate closely with cross-functional teams and provide key market insights to shape product development, pricing, and strategic initiatives.
Key Responsibilities:
- Develop and execute comprehensive business development and sales strategies for Biologics products
- Identify and pursue new business opportunities, attending industry events and partnering meetings
- Scope projects, prepare proposals, and negotiate contracts to secure new business
- Achieve sales targets and contribute to overall revenue growth
- Collaborate with marketing, sales, scientific, legal, contracting, and product management teams to drive business success
- Provide market intelligence to inform product development, pricing, and strategic partnerships
- Explore opportunities to cross-sell additional products
Minimum Requirements
- A minimum of a Bachelor's degree in a relevant science or engineering field; a Master's degree or PhD in life science is preferred.
- A minimum of 12 years of experience plus PhD (or equivalent experience with a Bachelor's)
- Proven business development experience with a successful track record (buy- or sell-side) within the biologics or life sciences industry
- Excellent communication and interpersonal skills with a demonstrated ability to build relationships with both internal and external stakeholders.
- Strong strategic planning and execution skills with a proven track record of achieving sales targets and driving revenue growth.
- Ability to work with urgency and be effective and collaborative in a cross-functional environment
Preferred Capabilities and Experience
- Strong technical understanding of biologics, particularly therapeutic antibodies and antibody developability
- Ability to proactively identify problems for potential clients and offer solutions through Ginkgo’s integrated service offerings
- Recognized business leader in biopharma, CDMOs, CROs
- Demonstrated networks to CSOs, Heads of Research, and Business Development at biotech and large pharma companies
- Prior experience within a fast-growth company or entrepreneurial environment is a plus.
- What is it really like to take your company public via a SPAC? One Boston biotech shares its journey (Fortune)
- Ginkgo Bioworks resizes the definition of going big in biotech, raising $2.5B in a record SPAC deal that weighs in with a whopping $15B-plus valuation (Endpoints News)
- Ginkgo Bioworks CEO on scaling up Covid-19 testing: ‘If we try, we can win’ (CNBC)
- Ginkgo raises $70 million to ramp up COVID-19 testing for employers, universities (Boston Globe)
- Ginkgo Bioworks Redirects Its Biotech Platform to Coronavirus (Wall Street Journal)
- Ginkgo Bioworks Provides Support on Process Optimization to Moderna for COVID-19 Response (PRNewswire)
- The Life Factory: Synthetic Organisms From This $1.4 Billion Startup Will Revolutionize Manufacturing (Forbes)
- Synthetic Bio Pioneer Ginkgo Raises $290 Million in New Funding (Bloomberg)
- Ginkgo Bioworks raises $350 million fund for biotech spinouts (Reuters)
- Can This Company Convince You to Love GMOs? (The Atlantic)
Apply for this job
*
indicates a required field